All posts by: Julia Albright PhD

An integral component of Multiple Sclerosis (MS) management is the ability to proficiently assess disease activity on MRIs from new and enlarging T2 FLAIR lesions. The latest release of the LesionQuant module of NeuroQuant (FDA cleared, CE marked) physicians can...
Continue Reading →
Are you curious if automated brain lesion segmentation tools can be both highly accurate and reproducible? To confirm this possibility, we compared our fully automated LesionQuant module against manual expert segmentation. Volumetric brain imaging is a powerful tool for providing...
Continue Reading →
Of the 1.5 million traumatic brain injuries (TBI) every year, 80% of them are considered mild. A “mild TBI”, often referred to as a concussion, is defined as loss of consciousness and/or confusion and disorientation, which is shorter than 30 minutes...
Continue Reading →
Volumetric brain imaging is a powerful tool for providing clinicians with clinical in vivo quantitative MRI biomarkers in their evaluation of many neurodegenerative conditions. Current clinical applications range from MCI, dementia (Alzheimer’s), MS, epilepsy to TBI and the list grows...
Continue Reading →
Previously, we discussed the importance of image distortion correction and alignment to a standard space, providing the ability to measure accurately and repeatedly and track brain volumes over time. Additionally, we examined how CorTechs Labs’ products deliver high image quality...
Continue Reading →
Less than perfect positioning Typically, in every MRI scan, the patient’s head and therefore the brain, is aligned slightly differently. This is primarily dependent on patient positioning, including variability of head rotation and tilt. Manual segmentation of MR images is...
Continue Reading →
CorTechs Labs’ patented Dynamic Atlas™ technology provides automatic segmentation and volume measurements for patients ranging from 3-100 years, with robust segmentation and goodness-of-fit across all age ranges to the atlas. Similar to using a map of the world to identify...
Continue Reading →
Head size, weight, and growth normative reference charts are used to evaluate infant and child development relative to age and gender. Similarly, NeuroQuant® provides context to patients’ brain structure volumes as compared to a data set established from a large...
Continue Reading →
Automated volumetric MR imaging offers an opportunity to extend brain atrophy measurements to the routine management of Multiple Sclerosis (MS) patients by showing regional and whole brain atrophy, which can be monitored over time. In MS patients, brain volume loss,...
Continue Reading →
According to the MS International Federation, multiple sclerosis (MS) is one of the most common diseases of the central nervous system, and more than 2,300,000 people worldwide are living with the diagnosis of MS. MS is defined as an immune-mediated...
Continue Reading →